Go Pro
→ The oil crisis is spreading faster than you think (From Golden Portfolio) (Ad)tc pixel Free LXEO Stock Alerts

Lexeo Therapeutics (LXEO) Short Interest Ratio & Short Volume

Lexeo Therapeutics logo
$4.79 +0.01 (+0.19%)
As of 09:35 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Lexeo Therapeutics Short Interest Overview

As of July 31, 2026, Lexeo Therapeutics (LXEO) had a short interest of 17.05 million shares sold short, representing 22.16% of the public float. This marks a 4.32% increase in short interest since the prior report. The short interest ratio (days to cover) is 16.9, meaning it would take 16.9 days of the average trading volume of 945,176 shares to cover all short positions.

Current Short Interest
17,054,582 shares
Previous Short Interest
16,348,536 shares
Change Vs. Previous Month
4.32%
Dollar Volume Sold Short
$70.44 million
Short Interest Ratio
16.9 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
78,522,000 shares
Short Percent of Float
22.16%
Today's Trading Volume
13,036 shares
Average Trading Volume
945,176 shares
Today's Volume Vs. Average
1%
Short Selling Lexeo Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Lexeo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LXEO Short Interest Over Time

LXEO Days to Cover Over Time

LXEO Percentage of Float Shorted Over Time

Lexeo Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202617,054,582 shares $70.44 million +4.3%22.2%16.87 $4.13
7/15/202616,348,536 shares $77.49 million +1.4%21.2%19.55 $4.74
6/30/202616,129,164 shares $75.16 million +14.5%21.0%14.02 $4.66
6/15/202614,088,171 shares $65.51 million +2.3%18.3%18.81 $4.65
5/29/202613,775,211 shares $70.80 million +4.3%18.5%17.36 $5.14
5/15/202613,212,896 shares $67.25 million +1.1%17.8%18.82 $5.09
4/30/202613,065,123 shares $74.47 million +3.7%17.6%18.92 $5.70
4/15/202612,604,284 shares $85.71 million +0.9%16.4%9.87 $6.80
3/31/202612,497,266 shares $71.73 million +5.9%16.2%14.14 $5.74
3/13/202611,797,859 shares $78.57 million +6.0%17.1%11.36 $6.66
2/27/202611,125,688 shares $79.88 million -2.9%16.1%19.05 $7.18
2/13/202611,459,188 shares $72.31 million -4.3%14.9%12.83 $6.31
1/30/202611,976,055 shares $88.74 million +4.5%17.3%14.55 $7.41
1/15/202611,456,768 shares $85.93 million +5.8%16.6%6.85 $7.50
12/31/202510,830,747 shares $107.55 million +52.5%15.7%5.85 $9.93
12/15/20257,101,931 shares $69.31 million +17.6%10.3%7.21 $9.76
11/28/20256,037,215 shares $59.37 million +7.1%8.7%5.76 $9.83
11/14/20255,636,938 shares $50.96 million +8.8%8.2%3.44 $9.04
10/31/20255,183,029 shares $51.88 million -29.2%10.1%3.97 $10.01
10/15/20257,320,000 shares $64.64 million +22.8%17.2%8.9 $8.83
9/30/20255,960,000 shares $39.57 million +1.2%14.0%9 $6.64
9/15/20255,890,000 shares $31.69 million +12.6%13.8%11.4 $5.38
8/31/20255,230,000 shares $25.05 million -1.0%11.2%11.6 $4.79
8/15/20255,280,000 shares $24.92 million +0.6%12.1%10.2 $4.72
7/31/20255,250,000 shares $24.83 million +1.4%22.9%8.5 $4.73
7/15/20255,180,000 shares $21.34 million +0.6%22.6%7.3 $4.12
6/30/20255,150,000 shares $20.70 million +7.7%22.5%5.7 $4.02
6/15/20254,780,000 shares $18.83 million +26.5%19.1%4.7 $3.94
5/31/20253,780,000 shares $10.43 million +21.5%15.1%3.8 $2.76
5/15/20253,110,000 shares $8.40 million -4.6%12.4%3.2 $2.70
4/30/20253,260,000 shares $12.81 million +10.9%13.0%3.7 $3.93
4/15/20252,940,000 shares $7.50 million +14.0%11.8%4 $2.55
3/31/20252,580,000 shares $8.95 million +16.2%10.3%3.9 $3.47
3/15/20252,220,000 shares $6.82 million -8.6%8.9%4.8 $3.07
2/28/20252,430,000 shares $6.95 million +5.2%9.8%7.5 $2.86
2/15/20252,310,000 shares $10.40 million +22.9%9.2%9 $4.50
1/31/20251,880,000 shares $10.21 million -18.6%8.0%5.3 $5.43
1/15/20252,310,000 shares $12.68 million +3.1%9.8%6.3 $5.49
12/31/20242,240,000 shares $14.74 million +9.3%9.4%5.9 $6.58
12/15/20242,050,000 shares $14.10 million -6.8%8.6%5.2 $6.88
A weekly dividend fund holding Nvidia and Palantir (Ad)

CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names distributes income every single Thursday, with payouts reported as high as $1,051 a month. Chief Income Strategist Tim Plaehn breaks down the fund's real Thursday distribution history, how the income is generated, and how to buy it in any brokerage account.tc pixel

Watch the free presentation before this Thursday's payout
11/30/20242,200,000 shares $18.11 million -11.7%9.2%5.1 $8.23
11/15/20242,490,000 shares $16.56 million +13.7%10.5%6.1 $6.65
10/31/20242,190,000 shares $17.30 million +6.3%9.8%7.6 $7.90
10/15/20242,060,000 shares $18.40 million -0.5%9.4%6.9 $8.93
9/30/20242,070,000 shares $18.71 million +74.0%9.4%6 $9.04
9/15/20241,190,000 shares $11.51 million -4.0%5.4%3.5 $9.67
8/31/20241,240,000 shares $14.27 million -36.1%5.7%4.1 $11.51
8/15/20241,940,000 shares $23.47 million +16.9%8.8%6.4 $12.10
7/31/20241,660,000 shares $20.83 million +97.5%7.7%5.6 $12.55
7/15/2024840,700 shares $10.94 million +8.4%3.9%3.2 $13.01
6/30/2024775,600 shares $12.44 million +23.4%3.6%4.6 $16.04
6/15/2024628,800 shares $10.93 million +15.8%2.9%4.4 $17.38
5/31/2024542,900 shares $9.03 million -20.7%3.1%3.6 $16.63
5/15/2024684,400 shares $9.55 million -1.7%4.5%5.3 $13.96
4/30/2024696,200 shares $8.67 million -16.8%4.3%5.9 $12.45
4/15/2024836,400 shares $10.11 million +6.8%5.2%8.1 $12.09
3/31/2024783,500 shares $12.29 million +63.4%4.9%7.3 $15.68
3/15/2024479,500 shares $7.47 million +41.3%3.0%4.4 $15.57
2/29/2024339,400 shares $4.96 million -3.6%2.1%3.6 $14.62
2/15/2024352,000 shares $5.36 million +16.8%2.8%3.6 $15.22
1/31/2024301,500 shares $5.17 million No Change2.4%2.8 $17.14

LXEO Short Interest - Frequently Asked Questions

Short interest is the volume of Lexeo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 17,054,582 shares of LXEO short. 22.16% of Lexeo Therapeutics' shares are currently sold short. Learn More on Lexeo Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LXEO shares currently have a short interest ratio of 16.9. Learn More on Lexeo Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.16% of Lexeo Therapeutics' floating shares are currently sold short.

Lexeo Therapeutics saw a increase in short interest in July. As of July 31st, there was short interest totaling 17,054,582 shares, an increase of 4.3% from the previous total of 16,348,536 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

22.16% of Lexeo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Lexeo Therapeutics: Monte Rosa Therapeutics, Inc. (20.61%), Absci Corporation (26.74%), MoonLake Immunotherapeutics (8.68%), Novavax, Inc. (28.22%), Oric Pharmaceuticals, Inc. (22.31%), Inhibrx Biosciences, Inc. (27.86%), Immatics N.V. (3.75%), Aktis Oncology (6.50%), Vor Biopharma Inc. (13.42%), MannKind Corporation (8.91%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling LXEO is an investing strategy that aims to generate trading profit from Lexeo Therapeutics as its price is falling. LXEO shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lexeo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LXEO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LXEO, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LXEO:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:LXEO is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
The trading strategy that works BECAUSE you have a life
Tim Sykes built a trading strategy for people who can't watch charts from 9:30 to 4:00 every day. It's not ...
Tim Sykes | Sponsoredtc pixel
Elon's Terrifying Warning: America Is "1,000% Going Bankrupt"
The national debt just crossed $39 trillion, and Elon Musk - former head of the Department of Government Effic...
American Hartford Gold | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
A $5 stock inside Kennedy Space Center?
A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken...
Freedom Financial | Sponsoredtc pixel
I found Rolls-Royce at $2 - now I see the same setup again
In 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...
Monument Traders Alliance | Sponsoredtc pixel
$8B is moving in... are you?
Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...
Awesomely | Sponsoredtc pixel